You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 11, September 19, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Malaria
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: As members of the public health authority that issues recommendations for malaria chemoprophylaxis for the Canadian Forces members, we were interested in the Research Letter by Dr Croft and colleagues1 regarding the differences in the approach to malaria prevention among armed forces deployed to Afghanistan. However, the data reported for Canada are inaccurate in that, after a reassessment of risk, the Canadian Forces discontinued the use of malaria chemoprophylaxis for members in Kabul in April 2005 and at Kandahar Air Field (from where the Canadian Forces primarily operates) in May 2006. Malaria chemoprophylaxis is still recommended outside these locations during the malaria season. Although mefloquine may be the drug most often selected, Canadian Forces members have the option of using either mefloquine weekly or doxycycline daily, with atovaquone/proguanil preferred when protection of short duration is needed.

The authors do not address the use of terminal prophylaxis with . . . [Full Text of this Article]

Martin Tepper, MD, MHSc, FRCPC
tepper.ml@forces.gc.ca

Steve Schofield, PhD; James Anderson, MD, MTM&H
Directorate of Force Health Protection
Canadian Forces Health Services Group Headquarters
Department of National Defence
Ottawa, Ontario, Canada



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan—Reply
Ashley M. Croft, Alicia H. Darbyshire, Christopher J. Jackson, and Pieter P. van Thiel
JAMA. 2007;298(11):1275-1276.
EXTRACT | FULL TEXT  

RELATED ARTICLE

An Outbreak of Malaria in US Army Rangers Returning From Afghanistan
Russ S. Kotwal, Robert B. Wenzel, Raymond A. Sterling, William D. Porter, Nikki N. Jordan, and Bruno P. Petruccelli
JAMA. 2005;293(2):212-216.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.